IRulya Therapeutics Inc. Common Stock (IRLA) is a publicly traded the market company. As of October 15, 2026, IRLA trades at $31.00 with a market cap of $28.35M and a P/E ratio of 0.00. IRLA moved +3.33% today. Year to date, IRLA is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $25.13 to $32.61. Rallies surfaces IRLA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
IRulya Therapeutics Inc. Common Stock (IRLA) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. IRLA moved +3.33% today.
| Metric | Value |
|---|---|
| Price | $31.00 |
| Market Cap | $28.35M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $32.61 |
| 52-Week Low | $25.13 |
| Volume | 4 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
IRLA analyst coverage data. Average price target: $0.00.